BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Stem Cells

The World Journal of Stem Cells (WJSC) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of stem cells.  It was launched on December 31, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage stem cells specialists worldwide to submit manuscripts to the WJSC describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJSC are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJSC’s acceptance rate: 62%. Submit here >>

2018 Published Issues
  • Tong Cao, DDS, PhD, President, Director, Doctor, Head, (E-mail:dencaot@nus.edu.sg)Department of Oral Sciences, National University of Singapore, Singapore 119083, Singapore
  • OK Kuang-Sheng Lee, MD, PhD, Professor, (E-mail:kslee@vghtpe.gov.tw)Department of Medical Research and Education, Medical Research and Education of Veterans General Hospital-Taipei, Taipei 11221, Taiwan
WJSC is now abstracted and indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, also known as SciSearch®), Journal Citation Reports/Science Edition, Biological Abstracts, and BIOSIS Previews.
Journal Metrics
The first impact factor of the WJSC will be issued in 2019.
1948-0210 (online)
Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease 
Maria Dorobantu, Nicoleta-Monica Popa-Fotea, Mihaela Popa, Iulia Rusu, Miruna Mihaela Micheu 
World J Stem Cells 9(12):203-218. Published online Dec 26, 2017. doi: 10.4252/wjsc.v9.i12.203
Yin and Yang of mesenchymal stem cells and aplastic anemia 
Larisa Broglie, David Margolis, Jeffrey A Medin 
World J Stem Cells 9(12):219-226. Published online Dec 26, 2017. doi: 10.4252/wjsc.v9.i12.219
Observational Study
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia 
Adriana Plesa, Charles Dumontet, Eve Mattei, Ines Tagoug, Sandrine Hayette, Pierre Sujobert, Isabelle Tigaud, Marie Pierre Pages, Youcef Chelghoum, Fiorenza Baracco, Helene Labussierre, Sophie Ducastelle, Etienne Paubelle, Franck Emmanuel Nicolini, Mohamed Elhamri, Lydia Campos, Claudiu Plesa, Stéphane Morisset, Gilles Salles, Yves Bertrand, Mauricette Michallet, Xavier Thomas 
World J Stem Cells 9(12):227-234. Published online Dec 26, 2017. doi: 10.4252/wjsc.v9.i12.227
Case Report
Umbilical cord blood stem cell treatment for a patient with psoriatic arthritis 
Margaret Coutts, Rowena Soriano, Rajendran Naidoo, Habib Torfi 
World J Stem Cells 9(12):235-240. Published online Dec 26, 2017. doi: 10.4252/wjsc.v9.i12.235